54
27
Growth Score 54 in past quarter
-7 pts
Heat Score 27 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
793782
Hemofarm is engages in the research, development, manufacture, sale, and export of generic pharmaceutical products.
About the Company
Hemofarm is engages in the research, development, manufacture, sale, and export of generic pharmaceutical products. It offers prescription drugs in the areas of cardiovascular diseases, antibiotics, and neuropsychiatric. The company also provides over the counter drugs, including magnetrons for exchange of energetic substances, bone structure,
electrolyte balance, and functioning of nervous system; and thiomucase, an enzyme that softens the connective tissue collagens. In addition, it offers dietary supplements.